Cardiovascular and renal disease burdens also occur in type 1 diabetes.
Read More »Children that Develop T2D Have Worse Clinical Outcomes and Fewer Treatment Options
When metformin therapy fails in youth, alternatives are limited to human insulin and liraglutide.
Read More »A1C as a Predictor of Mortality in Patients with Diabetes
Can variability in HbA1c lead to a higher risk of mortality in persons with diabetes?
Read More »The Link Between Type 2 Diabetes and Heart Failure
A Mendelian Randomization found a correlation between type 2 diabetes and heart failure, utilizing genetic markers.
Read More »Depression, Its Treatment, and Diabetes Risk
Loss of healthy behaviors due to depression may increase the risk of the development of type 2 diabetes.
Read More »Youth Type 2 Diabetes Linked to a Higher Risk of Diabetes-Related Complications
Does early-onset type 2 diabetes put young patients at a higher risk of developing comorbidities as they become adults?
Read More »ADA 81st Symposium: Are Point-Of-Care Devices Beneficial in Diagnosing Diabetic Neuropathy?
There is not much evidence-based literature on point-of-care devices, yet they are commonly used for diagnosis.
Read More »ADA 81st Symposium: The Combination of SGLT-2 inhibitors and GLP-1 Receptor Agonists
Can a new potential treatment combining an SGLT-2 and a GLP-1 RA mitigate cardiometabolic risk?
Read More »Ertugliflozin Proved Effective in Patients with Type 2 Diabetes and ASCVD
A VERTIS CV sub study showed significant improvements in glycemic control after adding ertugliflozin to insulin-based regimens.
Read More »ADA 81st Symposium: Evidence-Based Guidelines For Diabetes and Chronic Kidney Disease
Diabetes is the leading cause of chronic kidney disease due to microvascular damage to the renal blood vessels.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.